Overview
Nasopharyngeal carcinoma is a disorder.
Auto-generated from clinical reference data. Not a substitute for medical advice.
Research Evidence
Peer-reviewed studies linked via MeSH term "Carcinoma, Nasopharyngeal" from the MEDLINE/PubMed database.
Sort:
Efficacy and safety of molecular targeted therapies in nasopharyngeal carcinoma: a network meta-analysis.
[object Object], [object Object], [object Object] et al. · BMC Cancer · 2025
Chronic rhinosinusitis in nasopharyngeal carcinoma patients post- IMRT: a meta-analysis.
[object Object], [object Object], [object Object] et al. · Rhinology · 2025
PMID: 40406956Meta-Analysis
Efficacy and safety of immune checkpoint inhibitors in the treatment of recurrent or metastatic nasopharyngeal carcinoma: A systematic review and meta-analysis.
[object Object], [object Object], [object Object] et al. · Chin Med J (Engl) · 2025
Comparison of TPF and PF induction chemotherapy combined with cisplatin concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: A systematic review and meta-analysis.
[object Object], [object Object], [object Object] et al. · Medicine (Baltimore) · 2025
Advances in individualization of systemic treatment for locoregionally advanced nasopharyngeal carcinoma: a systematic review.
[object Object], [object Object], [object Object] · ESMO Open · 2025
Margins in oncologic nasopharyngeal surgery: a systematic review with meta-analysis.
[object Object], [object Object], [object Object] et al. · Acta Otorhinolaryngol Ital · 2025
Maintenance treatment with oral anticancer agents after first-line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis.
[object Object], [object Object], [object Object] · Eur Arch Otorhinolaryngol · 2025
PMID: 39198304Meta-Analysis
Concurrent Chemoradiotherapy versus Radiotherapy Alone in the Treatment of Stage II and T3N0M0 Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis.
[object Object], [object Object], [object Object] et al. · Clin Oncol (R Coll Radiol) · 2025
PMID: 39455344Meta-Analysis
Efficacy and safety of PD-1 inhibitor plus chemotherapy in advanced nasopharyngeal carcinoma: A meta-analysis.
[object Object], [object Object], [object Object] et al. · Tumori · 2025
PMID: 39797440Meta-Analysis
Clinical features and outcomes of skull base osteoradionecrosis in nasopharyngeal carcinoma patients: a systematic review and meta-analysis.
[object Object], [object Object], [object Object] et al. · Rhinology · 2025
PMID: 40445072Meta-Analysis
Search all PubMed articles for Nasopharyngeal carcinoma
Research data from MEDLINE/PubMed
Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
Nasopharyngeal neoplasm
HP:0100630
Quick Facts
- SNOMED CT
- 449248000
- UMLS CUI
- C2931822
- Fully Specified Name
- Nasopharyngeal carcinoma (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 1
Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.